The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
New Alzheimer's Biomarkers may Support Early Diagnosis
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
